Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
7.08
+0.22 (3.21%)
At close: Aug 25, 2026, 4:00 PM EDT
7.10
+0.02 (0.28%)
After-hours: Aug 25, 2026, 7:57 PM EDT

Verastem Revenue

Verastem had revenue of $40.08M in the quarter ending June 30, 2026, with 1,775.43% growth. This brings the company's revenue in the last twelve months to $87.53M, up 3,995.74% year-over-year. In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth.

Revenue (ttm)
$87.53M
Revenue Growth
+3,995.74%
P/S Ratio
7.33
Revenue / Employee
$858,098
Employees
102
Market Cap
641.19M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix462.25M
MiMedx Group355.17M
Arvinas316.70M
Autolus Therapeutics117.39M
OmniAb38.46M
Scribe Therapeutics36.28M
Prime Medicine4.07M
Altimmune31.00K
Revenue Rankings

VSTM News

More News